Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Czechia / NCT07432009
Recruiting Observational

Orthopedic Procedures and Postoperative Delirium in Older Adults in the Czech Republic

NCT07432009 · tracked via the Priya Life Science Czechia tracker
Phase
Observational
Started
2026-04-24
Last updated
2026-07-09

Condition(s) studied

FrailtyCognitive ImpairmentOlder AdultsHip ArthroplastyPostoperative Delirium

Study summary

This multicenter, prospective, non-interventional observational study (ORTOPODCZ) investigates the association between preoperative cognitive impairment and postoperative delirium (POD) in older adults undergoing elective total hip arthroplasty in the Czech Republic. Postoperative delirium is a frequent and serious neurocognitive complication in senior surgical patients and is associated with increased morbidity, mortality, prolonged hospitalization, and impaired functional and cognitive outcomes. Despite international recommendations, routine preoperative cognitive screening remains insufficiently implemented.

The study evaluates the predictive value of the ALBA test, a brief cognitive screening tool, performed during the pre-anesthetic assessment. Postoperative delirium will be assessed using the validated CAM-ICU instrument for up to 72 hours after surgery. Secondary objectives include assessing the relationship between POD and frailty, polypharmacy, comorbidities, type of anesthesia, intraoperative hemodynamics, blood loss, vasoactive support, and postoperative complications.

Approximately 300-400 participants aged ≥65 years will be enrolled across seven centers. No additional procedures, biological sampling, or deviations from standard clinical care are required. Data will be collected in REDCap and analyzed according to a predefined statistical analysis plan. The study aims to provide robust evidence supporting the integration of cognitive screening into routine preoperative evaluation and to describe feasibility and implementation requirements for the ALBA test in clinical practice.

Eligibility

Sex
ALL
Min age
65 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Age ≥ 65 years * Elective total hip arthroplasty in general or regional anesthesia * ASA physical status I-III * Ability to understand and cooperate during testing; no severe sensory impairment (compensatory aids allowed) * Expected postoperative hospitalization in ICU, PACU, or standard ward Exclusion Criteria: * Glasgow Coma Scale ≤ 14 * Limited legal capacity * Active psychiatric disorder (e.g., psychotic disorder, bipolar disorder) * Active oncological disease * Chronic use of strong opioids * Premedication with anxiolytics or antipsychotics during preanesthetic evaluation * Acute reoperation within 3 months of primary surgery * Refusal to participate or withdrawal of consent

Primary outcome measure(s)

Trial sites (7)

FacilityCityRegionStatus
University Hospital Brno - Bohunice Brno Czechia Not Yet Recruiting
University Hospital Olomouc - Department of Anaesthesiology, Resuscitation and Intensive Care Olomouc Czechia Not Yet Recruiting
University Hospital Ostrava - Department of Anaesthesiology, Resuscitation and Intensive Care Ostrava Czechia Not Yet Recruiting
University Hospital Královské Vinohrady Prague Czechia Not Yet Recruiting
University Hospital Motol Prague Czechia Not Yet Recruiting
Vsetín Hospital Vsetín Czechia Not Yet Recruiting
Tomas Bata Regional Hospital Zlín Czechia Recruiting

More Tomas Bata Hospital, Czech Republic trials in Czechia

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07432009 on ClinicalTrials.gov ↗ ← All trials in Czechia